Norsk Hydro: Second quarter 2014: All-in metal price rise

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Norsk Hydro: Second quarter 2014: All-in metal price rise continues, seasonally lower Energy results

OSLO, Norway, July 22, 2014 (GLOBE NEWSWIRE) -- Norsk Hydro ASA's underlying earnings before financial items and tax (EBIT) declined to NOK 544 million in the second quarter from NOK 772 million in the first quarter. Seasonally lower power production and prices weighed on underlying results, partly offset by higher all-in metal prices and improved results in Primary Metal.

  • Underlying EBIT NOK 544 million
  • Higher all-in aluminium and realized alumina prices
  • Alunorte production at record-high levels
  • Seasonally lower power production and prices
  • World outside China primary aluminium demand continues to exceed production
  • Signed agreement to take over Søral primary plant

"Aluminium demand continues to exceed production resulting in a tight market, and we see the all-in metal prices at their highest levels since 2012. We are continuing our efforts to improve along the entire value chain, and Qatalum has now achieved a cost position among the 10 best aluminium plants in the world," said President and CEO Svein Richard Brandtzæg.

Underlying EBIT for Bauxite & Alumina remained weak, but improved somewhat compared to first quarter of 2014 influenced by higher realized alumina prices and increased alumina sales volumes. Positive developments were mostly offset by negative currency developments and higher energy costs due to ICMS taxes for the full quarter.

"I am happy to see production at record-high levels above 6 million tons annualized at the Alunorte alumina refinery in Brazil, but regretfully results are still weak. However, our "From B to A" improvement program is on track, and the results should start impacting the bottom-line in the coming quarters," said Brandtzæg.

Underlying EBIT for Primary Metal improved in the second quarter influenced by higher product premiums, partly offset by lower sales volumes and somewhat lower realized aluminium prices.

Metal Markets delivered a lower underlying EBIT compared to the previous quarter mainly due to decreased results from sourcing and trading activities partly offset by higher volumes at remelters.

"It has been an eventful quarter: We signed an agreement to take over the Søral primary plant and its products fit well with Hydro's high premium casthouse strategy. We signed four power contracts, securing parts of our external power sourcing need after 2020. Also, Enova granted Hydro support to build the world's most energy efficient aluminium pilot. This is an important step for Hydro's ambition to become carbon neutral by 2020 and a pillar in our strategy to develop the hydropower-based Norwegian aluminium portfolio," said Brandtzæg.

Underlying EBIT for Rolled Products was stable compared to the first quarter.

Compared to the first quarter of 2014, underlying EBIT for Energy declined mainly due to seasonally lower power production and lower prices in our production areas.

Underlying results for Sapa improved during the quarter, partly influenced by seasonally stronger sales volumes.

Operating cash flow amounted to NOK 1.0 billion for the second quarter including roughly NOK 0.5 billion of dividends from Qatalum. Net cash used for investment activities amounted to NOK 0.7 billion. Dividends paid during the quarter amounted to NOK 1.6 billion. Hydro's net debt position amounted to around NOK 1.9 billion at the end of the second quarter.

Reported earnings before financial items and tax amounted to NOK 620 million in the second quarter. In addition to the factors discussed above, reported EBIT included net unrealized derivative gains and positive metal effects of NOK 154 million in total. Reported earnings also included charges of NOK 87 million (Hydro's share) in Sapa primarily related to rationalization activities.

In the previous quarter reported earnings before financial items and tax amounted to NOK 822 million including net unrealized derivative gains amounting to NOK 170 million in total. Reported earnings also included impairment charges of NOK 33 million related to the divestment of Hydro's casthouse in Hannover and charges of NOK 86 million (Hydro's share) in Sapa primarily related to rationalization activities.

Income from continuing operations amounted to NOK 269 million in the second quarter including a net foreign exchange loss of NOK 101 million. In the previous quarter, income from continuing operations amounted to NOK 462 million including a net foreign exchange gain of NOK 193 million.

Key financial information

NOK million, except per share data
Second quarter 2014 First quarter 2014 %change prior quarter Second quarter 2013 %change prior year quarter First  half 2014 First  half 2013 Year 2013
Revenue 18 272 18 282 - 16 052 14 % 36 553 32 161 64 877
Earnings before financial items and tax (EBIT) 620 822 (25) % 376 65 % 1 442 1 081 1 663
Items excluded from underlying EBIT (75) (50) (49) % 144 >(100) % (126) 516 1 063
Underlying EBIT 544 772 (29) % 520 5 % 1 316 1 596 2 725
Underlying EBIT :
Bauxite & Alumina (269) (288) 7 % (244) (10) % (557) (308) (1 057)
Primary Metal 420 312 35 % 237 77 % 732 602 1 422
Metal Markets 100 141 (30) % 147 (32) % 241 292 594
Rolled Products 177 181 (2) % 183 (3) % 358 334 615
Energy 169 435 (61) % 268 (37) % 603 784 1 653
Other and eliminations (52) (8) >(100) % (70) 26 % (61) (109) (502)
Underlying EBIT 544 772 (29) % 520 5 % 1 316 1 596 2 725
Underlying EBITDA 1 653 1 861 (11) % 1 674 (1) % 3 514 3 886 7 306
Underlying income (loss) from discontinued operations - - - 112 (100) % - 163 220
Net income (loss) 269 462 (42) % (665) >100 % 730 (402) (839)
Underlying net income (loss) 318 388 (18) % 427 (26) % 705 1 075 1 610
Earnings per share 0.09 0.19 (53) % (0.31) >100 % 0.28 (0.17) (0.45)
Underlying earnings per share 0.13 0.16 (21) % 0.19 (33) % 0.29 0.49 0.65
Financial data:
Investments 740 546 36 % 652 14 % 1 286 1 729 3 761
Adjusted net interest-bearing debt (13 551) (11 230) (21) % (11 857) (14) % (13 551) (11 857) (10 128)
Key Operational information
Alumina production (kmt) 1 526 1  428 7 % 1 248 22 % 2 954 2 609 5 377
Primary aluminium production (kmt) 488 484 1 % 483 1 % 972 961 1 944
Realized aluminium price LME (USD/mt)       1 762         1 749 1 %     1 926 (9) %          1 755           1 986          1 902
Realized aluminium price LME (NOK/mt)    10 660       10 702              -      11 217 (5) %       10 682         11 378         11 160
Realized NOK/USD exchange rate 6.05 6.12 (1) % 5.82 4 % 6.09 5.73 5.87
Metal products sales, total Hydro (kmt)         843             871 (3) %                  789 7 %          1 714   1 595     3 164
Rolled Products sales volumes to external market (kmt) 245 243 1 % 245              - 488 482 941
Power production (GWh) 2 248 2 964 (24) % 2 090 8 % 5 212 4 993 10 243

Investor contact
Contact Pål Kildemo
Cellular +47 97096711
E-mail Pal.Kildemo@hydro.com

Press contact
Contact Halvor Molland
Cellular +47 92979797
E-mail Halvor.Molland@hydro.com

Certain statements included within this announcement contain forward-looking information, including, without limitation, those relating to (a) forecasts, projections and estimates, (b) statements of management's plans, objectives and strategies for Hydro, such as planned expansions, investments or other projects, (c) targeted production volumes and costs, capacities or rates, start up costs, cost reductions and profit objectives, (d) various expectations about future developments in Hydro's markets, particularly prices, supply and demand and competition, (e) results of operations, (f) margins, (g) growth rates, (h) risk management, as well as (i) statements preceded by "expected", "scheduled", "targeted", "planned", "proposed", "intended" or similar statements.

Although we believe that the expectations reflected in such forward-looking statements are reasonable, these forward-looking statements are based on a number of assumptions and forecasts that, by their nature, involve risk and uncertainty. Various factors could cause our actual results to differ materially from those projected in a forward-looking statement or affect the extent to which a particular projection is realized. Factors that could cause these differences include, but are not limited to: our continued ability to reposition and restructure our upstream and downstream aluminium business; changes in availability and cost of energy and raw materials; global supply and demand for aluminium and aluminium products; world economic growth, including rates of inflation and industrial production; changes in the relative value of currencies and the value of commodity contracts; trends in Hydro's key markets and competition; and legislative, regulatory and political factors.

No assurance can be given that such expectations will prove to have been correct. Hydro disclaims any obligation to update or revise any forward looking statements, whether as a result of new information, future events or otherwise.


This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Q2 Report http://hugin.info/106/R/1832530/636150.pdf
Q2 Presentation http://hugin.info/106/R/1832530/636151.pdf

HUG#1832530

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 139

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 190

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Kearney's 2025 Global Cities Report Insights

Updated Category News Views 654

Global Cities Adapt to New Challenges and Emergence Global cities hold steady at the top as new hubs surge forward Top cities reaffirm their dominance in the Global Cities Index, showcasing remarkable resilience amidst global changes and uncertainties. The Global Cities Outlook indicates a noticeable shift as traditional leaders face turbulence, while emerging Gulf and...

Continue Reading
Vacca Family Law Group Enhances Support for Peaceful Divorce

Updated Category News Views 255

Empowering Families Through Non-Adversarial Divorce Solutions Families navigating the challenging process of separation now have renewed access to considerate and non-confrontational divorce options. Vacca Family Law Group has recently welcomed Attorney and Mediator Wendy Reimer, who brings nearly two decades of experience in family law and a strong background in...

Continue Reading
Ingredion Delivers Impressive Q3 Results, Upgrades Outlook

Updated Category News Views 55

Ingredion's Strong Performance in the Third Quarter Ingredion Incorporated (NYSE: INGR) has reported remarkable results for the third quarter of 2024, showcasing a noteworthy surge in both operating income and earnings per share (EPS). The global leader in ingredient solutions for the food and beverage industry achieved a stunning 26% increase in reported operating income...

Continue Reading
Insight into Learning Technologies Group Plc's Disclosure Mechanism

Updated Category News Views 193

Understanding the Public Opening Position Disclosure Process In the complex world of financial securities, understanding the disclosure requirements can feel daunting. However, the process outlined by the Takeover Code, particularly Rule 8.3, provides a structured approach for individuals and entities holding significant interests in relevant securities. This rule is...

Continue Reading
Avidity Biosciences Set to Inspire with Latest Presentations

Updated Category News Views 191

Avidity Biosciences' Key Presentations at the MDA Conference Avidity Biosciences, Inc. (Nasdaq: RNA), a pioneer in RNA therapeutics, is poised to make a significant impact at the upcoming Clinical and Scientific Conference organized by the Muscular Dystrophy Association (MDA). The event will showcase the latest advancements in the field and highlight groundbreaking...

Continue Reading